Production (Stage)
PureTech Health plc
PRTC
$18.20
-$0.80-4.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 1,476.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 1,476.39% | |||
| Cost of Revenue | 0.00% | -22.16% | |||
| Gross Profit | 0.00% | 33.33% | |||
| SG&A Expenses | 0.00% | 57.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 10.98% | |||
| Operating Income | 0.00% | -4.63% | |||
| Income Before Tax | 0.00% | 243.20% | |||
| Income Tax Expenses | 0.00% | 134.80% | |||
| Earnings from Continuing Operations | 0.00% | 256.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 161.81% | |||
| Net Income | 0.00% | 328.10% | |||
| EBIT | 0.00% | -4.63% | |||
| EBITDA | -0.44% | -5.70% | |||
| EPS Basic | 0.00% | 356.90% | |||
| Normalized Basic EPS | 0.00% | 51.38% | |||
| EPS Diluted | 0.00% | 350.71% | |||
| Normalized Diluted EPS | 0.00% | 51.97% | |||
| Average Basic Shares Outstanding | 0.00% | -11.27% | |||
| Average Diluted Shares Outstanding | 0.00% | -10.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||